EPIDEMIOLOGY OF KSHV AND AIDS-RELATED KAPOSIS SARCOMA
KSHV 和艾滋病相关卡波西斯肉瘤的流行病学
基本信息
- 批准号:2896228
- 负责人:
- 金额:$ 22.86万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1997
- 资助国家:美国
- 起止时间:1997-09-01 至 2001-08-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (adapted from the Abstract): The goal of this study is to
define the epidemiology of HIV-1 related Kaposi's sarcoma (KS) as it relates
to the putative causal agent, KS herpes virus (KSHV). A proposed historical
cohort study nested within the Multicenter AIDS Cohort Study (MACS), a
longitudinal prospective study of the natural history of HIV-1 infection in
homosexual/ bisexual men, will address these specific aims: (1) determine
the prevalence and incidence of KSHV infection in this population; (2)
determine the KSHV route of transmission and the concordance of
characteristics associated with the virus to risk factors for KS; (3)
determine rates and biological markers of progression to KS among KSHV
seropositive, HIV-1 infected homosexual men and factors which may modify
disease progression; (4) examine the effect of anti-retroviral and
anti-herpes treatments on KS disease progression in the presence of KSHV
infection; and (5) examine the health effects of KSHV in the absence of
HIV-1 and the effect of KSHV on HIV-1 progression independent of its role in
KS disease. Behaviors to be examined as risk factors include numbers of
male sexual partners and types of sexual activities (e.g., anal/genital
intercourse, anal/oral intercourse, genital/oral intercourse) and
recreational drug use (e.g., nitrite inhalants). Host characteristics
including age, race and immune status will be examined as effect modifiers
for viral acquisition and disease progression. The effects of other
environmental factors such as geographic location and co-infections will be
studied, also. KSHV serological testing will be performed on selected
visits for 414 HIV-1 seroconverters with known dates of seroconversion
within 1 year and a stratified random sample of 400 HIV-1 seroprevalent and
100 seronegative men. KSHV seroprevalence also will be determined in a
sample of injecting drug users from a cohort study with protocols similar as
the MACS. Establishing the epidemiology of the KSHV, consistent with
principles of causality, will provide direction for developing behavioral
and therapeutic interventions against the development of KS and will guide
virological and biological investigations determining the pathogenesis of
this disease.
描述(改编自摘要):本研究的目标是
界定与HIV-1相关的卡波西肉瘤(KS)的流行病学
可能的病原体是KS疱疹病毒(KSHV)。一项拟议的历史
嵌套在多中心艾滋病队列研究(MACS)中的队列研究,a
安徽省HIV-1感染自然史的纵向前瞻性研究
男同性恋者/双性恋者,将解决这些具体目标:(1)确定
该人群中KSHV感染的患病率和发病率;(2)
确定KSHV传播途径及其与
与病毒相关的特征与KS的危险因素;(3)
KSHV向KS进展率及生物学标志的测定
血清阳性、感染HIV-1的同性恋男性及其可能改变的因素
疾病进展;(4)检测抗逆转录病毒和
抗疱疹治疗对KSHV感染的KS疾病进展的影响
感染;以及(5)在没有KSHV感染的情况下检查KSHV对健康的影响
HIV-1及KSHV对HIV-1进展的影响
KS病。作为风险因素进行审查的行为包括
男性性伙伴和性活动类型(例如,肛门/生殖器
性交、肛交/口交、生殖器/口交)和
娱乐用药(例如亚硝酸盐吸入剂)。寄主特征
包括年龄、种族和免疫状况在内的因素将作为效果修饰物进行检查
用于病毒感染和疾病进展。其他因素的影响
地理位置和混合感染等环境因素将是
也学过了。将对选定的KSHV进行血清学检测
已知血清转换日期的414名HIV-1血清转换者的就诊情况
在1年内,对400名HIV-1血清流行者和
100名血清阴性的男性。KSHV血清阳性率也将在
一项队列研究中注射吸毒者的样本,方案类似于
Mac电脑。建立KSHV的流行病学,与
因果关系原则,将为行为学的发展提供方向
和针对KS发展的治疗干预,并将指导
病毒学和生物学研究确定该病的发病机制
这种病。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
CD8+ cytotoxic T lymphocyte responses to lytic proteins of human herpes virus 8 in human immunodeficiency virus type 1-infected and -uninfected individuals.
在人类免疫缺陷病毒 1 型感染和未感染个体中,CD8 细胞毒性 T 淋巴细胞对人类疱疹病毒 8 裂解蛋白的反应。
- DOI:10.1086/315777
- 发表时间:2000
- 期刊:
- 影响因子:0
- 作者:Wang,QJ;Jenkins,FJ;Jacobson,LP;Meng,YX;Pellett,PE;Kingsley,LA;Kousoulas,KG;Baghian,A;RinaldoJr,CR
- 通讯作者:RinaldoJr,CR
Identification of an HLA A*0201-restricted CD8(+) T-cell epitope for the glycoprotein B homolog of human herpesvirus 8.
- DOI:10.1182/blood.v99.9.3360
- 发表时间:2002-05
- 期刊:
- 影响因子:20.3
- 作者:Qiong J. Wang;Xiao-li Huang;G. Rappocciolo;F. Jenkins;W. Hildebrand;Zheng Fan;E. Thomas;C. Rinaldo
- 通讯作者:Qiong J. Wang;Xiao-li Huang;G. Rappocciolo;F. Jenkins;W. Hildebrand;Zheng Fan;E. Thomas;C. Rinaldo
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LISA P JACOBSON其他文献
LISA P JACOBSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LISA P JACOBSON', 18)}}的其他基金
ECHODAC (Environmental Influences on Child Health Outcomes Data Analysis Center)
ECHODAC(环境对儿童健康结果的影响数据分析中心)
- 批准号:
9355710 - 财政年份:2016
- 资助金额:
$ 22.86万 - 项目类别:
ECHODAC (Environmental Influences on Child Health Outcomes Data Analysis Center)
ECHODAC(环境对儿童健康结果的影响数据分析中心)
- 批准号:
10015366 - 财政年份:2016
- 资助金额:
$ 22.86万 - 项目类别:
Center/Coordination, Analysis and Management/MACS
中心/协调、分析与管理/MACS
- 批准号:
8072924 - 财政年份:2010
- 资助金额:
$ 22.86万 - 项目类别:
Center for the Analysis & Management of the Multicenter AIDS Cohort Study
分析中心
- 批准号:
7725473 - 财政年份:2009
- 资助金额:
$ 22.86万 - 项目类别:
Center/Coordination, Analysis and Management/MACS
中心/协调、分析与管理/MACS
- 批准号:
7924394 - 财政年份:2009
- 资助金额:
$ 22.86万 - 项目类别:
EPIDEMIOLOGY OF KSHV AND AIDS-RELATED KAPOSIS SARCOMA
KSHV 和艾滋病相关卡波西斯肉瘤的流行病学
- 批准号:
2769985 - 财政年份:1997
- 资助金额:
$ 22.86万 - 项目类别:
EPIDEMIOLOGY OF KSHV AND AIDS-RELATED KAPOSIS SARCOMA
KSHV 和艾滋病相关卡波西斯肉瘤的流行病学
- 批准号:
2439683 - 财政年份:1997
- 资助金额:
$ 22.86万 - 项目类别:
EPIDEMIOLOGY OF KSHV AND AIDS RELATED KAPOSIS SARCOMA
KSHV 和艾滋病相关卡波西斯肉瘤的流行病学
- 批准号:
2878002 - 财政年份:1997
- 资助金额:
$ 22.86万 - 项目类别:
Center/Coordination, Analysis and Management/MACS
中心/协调、分析与管理/MACS
- 批准号:
8242864 - 财政年份:1993
- 资助金额:
$ 22.86万 - 项目类别:
Center/Coordination, Analysis and Management/MACS
中心/协调、分析与管理/MACS
- 批准号:
7638686 - 财政年份:1993
- 资助金额:
$ 22.86万 - 项目类别:
相似海外基金
FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
- 批准号:
EP/Y036395/1 - 财政年份:2024
- 资助金额:
$ 22.86万 - 项目类别:
Research Grant
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
- 批准号:
10715568 - 财政年份:2023
- 资助金额:
$ 22.86万 - 项目类别:
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
- 批准号:
10764456 - 财政年份:2023
- 资助金额:
$ 22.86万 - 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
- 批准号:
10743328 - 财政年份:2023
- 资助金额:
$ 22.86万 - 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
- 批准号:
10638813 - 财政年份:2023
- 资助金额:
$ 22.86万 - 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
- 批准号:
10828665 - 财政年份:2023
- 资助金额:
$ 22.86万 - 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
- 批准号:
10823828 - 财政年份:2023
- 资助金额:
$ 22.86万 - 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
- 批准号:
10721095 - 财政年份:2023
- 资助金额:
$ 22.86万 - 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
- 批准号:
10795328 - 财政年份:2023
- 资助金额:
$ 22.86万 - 项目类别:
Clinical Research and Academic Success in Obstetrics & Gynecology
产科临床研究和学术成就
- 批准号:
10828252 - 财政年份:2023
- 资助金额:
$ 22.86万 - 项目类别:














{{item.name}}会员




